Part 3: Should I Consider Two-Drug Regimens for Most Patients in My Practice or for Just a Select Few? - Innovative ART Paradigms - Video Module - Innovative ART - HIV

Part 3: Should I Consider Two-Drug Regimens for Most Patients in My Practice or for Just a Select Few? (6 mins)

Hear the panel’s thoughts on when to consider oral two-drug regimens

Chloe Orkin, MBChB, FRCP, MD
Program Director

Andrea Mantsios, PhD

Anthony M. Mills, MD

Omar Sued, MD, PhD

Babafemi Taiwo, MBBS

Released: August 26, 2019 Expiration: No longer available for credit

Dr Sylvia Ojoo discusses data on cryptococcal meningitis in people with HIV from the fall 2022 HIV conferences, from Clinical Care Options (CCO)

Sylvia Ojoo, CCST (UK), MRCP (UK), DTM&H (UK), DFFP (UK), MBChB Released: December 6, 2022

ClinicalThought

Dr Monica Gandhi discusses key advances in HIV treatment over the past year, from Clinical Care Options (CCO)

Monica Gandhi, MD, MPH Released: December 2, 2022

ClinicalThought

A patient advocate discusses the importance of community-led HIV treatment and prevention, from Clinical Care Options (CCO)

Rena Janamnuaysook, MBA Released: December 2, 2022

Multimedia

Clinical Care Options (CCO) expert analysis of new data from IDWeek and HIV Glasgow 2022, provided by expert HIV faculty

Joseph J. Eron, Jr., MD

Karine Lacombe, MD, PhD Released: November 30, 2022

Part 3: Should I Consider Two-Drug Regimens for Most Patients in My Practice or for Just a Select Few? (6 mins)